New StemSpan™ SFEM II Media for Unparalleled Hematopoietic Cell Expansion

STEMCELL Technologies Inc. have launched a new serum-free culture medium known as StemSpan™ SFEM II to support the expansion of hematopoietic stem cell cultures. It provides a 40% higher expansion of the human progenitor CD34+ cells from human cord blood and bone marrow, in comparison to six leading commercially available serum-free media. StemSpan™ SFEM II allows researchers to expand valuable human cell samples and generate stocks of primitive hematopoietic progenitors for further research applications.

“StemSpan™ SFEM II supports equivalent total nuclear cell and superior CD34+ cell expansion as the existing highest performance serum-free media on the market,” said Dr. Bert Wognum, the senior scientist responsible for hematopoietic stem cell expansion medium development at STEMCELL Technologies. “It also supports erythroid and megakaryocyte expansion and may be used by researchers to develop and optimize their own culture systems to generate large numbers of other mature blood cells.”

“We are delighted to support hematopoietic stem cell researchers by providing StemSpan™ SFEM II, allowing them increased flexibility in experimental design for applications requiring large numbers of hematopoietic progenitors” said Dr. Allen Eaves, CEO and President of STEMCELL Technologies.

The high-quality StemSpan™ serum-free media products include StemSpan™ SFEM, StemSpan™ SFEM II, StemSpan™ H3000 and StemSpan™ ACF for ex vivo expansion of hematopoietic progenitor cells.